Issues related to enhanced cancer treatment and research; and issues related to health care access and health care coverage.
2026 · 1st Quarter (Jan 1 - Mar 31)
OREGON HEALTH & SCIENCE UNIVERSITY
Filed by OREGON HEALTH & SCIENCE UNIVERSITY.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- Not reported
- Expenses
- $100,000.00
- Registrant
- OREGON HEALTH & SCIENCE UNIVERSITY
- Filing UUID
- c8eef008-ff7c-4c81-ab6a-a9ece70419c1
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to biomedical research and nonhuman primates.
Issues related to the 340B Drug Pricing Program.
Issues related to Graduate Medical Education and federal student financial aid programs.
Fiscal 2027 appropriations related to federal research programs, health professions and nursing education workforce development and training and public health programs, including National Institutes of Health and HRSA Title VII and VIII funding.
Issues related to Medicare-Medicaid financing and policy.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.